Global Group Head Biostatistics

Job Description Summary

\Onsite
#LI-Onsite
East Hanover, New Jersey

About the role:
In this role, you will serve as Global Group Head (GGH) Biostatistics in the renal disease area in the Oncology development unit. As a quantitative leader, the GGH fosters the AQS vision of being an agile and innovative, technologically advanced and strategic partner in drug development, influencing clinical development strategy/ trial design and cultivating an exploratory mindset utilizing effective visualizations.

 

Job Description

Your Key Responsibilities:

• As disease/ therapy area leader you will foster effective quantitative support with scientific innovation and regulatory rigor across projects in the disease area and facilitate the seamless transition of projects from early to late phase development

• As inspirational people leader of up to 20 Biostatisticians you will support associates to be their best, with targeted hiring, assignment, development and retention

• As line function builder you will define and lead functional initiatives and facilitate knowledge sharing

• As role model collaborator you will build connections with other cross-functional leaders at the portfolio and disease area level, as well as externally across industry and with regulators

• As partner to senior clinical and scientific leadership, you will drive strategic statistical input to and excellence in drug development in Oncology

• As representative of the biostatistics function, you will attend internal and external decision boards
   

Video Link  https://www.youtube.com/watch?v=ggbnzRY9z8w 
 

This position will be located in the East Hanover, NJ site and will not be available remotely.
 

Role Requirements:
Essential Requirements:

• Master’s Degree in Statistics or equivalent, and 14+ years relevant work experience or PhD and 10+ years relevant work experience.

• Ability to influence decision making through the development of innovative options and use of quantitative statistics for highly complex projects.

• Extensive knowledge of applying cutting edge statistical methods; expert understanding of the drug development process.

• Record of successful implementation of novel methods and/ or innovative strategies in drug development.

• Ability to recognize opportunities where machine learning, computer science and new technologies add value.

• Significant experience in Health Authority activities.

• Experience of leveraging and maximizing the contributions of diverse teams.
   

Novartis Compensation and Benefit Summary:

The salary for this position is expected to range between $185,500 and $344,500 per year.  The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards. US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.  To learn more about the culture, rewards and benefits we offer our people click here.
 

Why Novartis:
Our purpose is to reimagine medicine to improve and extend people’s lives and our vision is to become the most valued and trusted medicines company in the world. How can we achieve this? With our people. It is our associates that drive us each day to reach our ambitions. Be a part of this mission and join us! Learn more here: https://www.novartis.com/about/strategy/people-and-culture

You’ll receive:

You can find everything you need to know about our benefits and rewards in the Novartis Life Handbook.

https://www.novartis.com/careers/benefits-rewards

Accessibility and Reasonable Accommodations: Th